Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

January 9, 2017

(HealthDay)—Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), according to a study published online Jan. 4 in Diabetes.

Amalia Gastaldelli, Ph.D., from the University of Texas Health Science Center at San Antonio, and colleagues examined the role of Adipo-IR in a large group of NGT, IGT, and T2DM subjects. The authors evaluated Adipo-IR, peripheral IR, and β-cell function in 302 subjects with varying .

The researchers found that, compared with lean-NGT, fasting Adipo-IR was increased two-fold in obese-NGT and IGT and three-fold in T2DM (4.1 ± 0.3 versus 8.0 ± 1.1, 9.2 ± 0.7, and 11.9 ± 0.6, respectively). Progressive decline in β-cell function correlated with a progressive impairment in free fatty acid (FFA) suppression during the test; when subjects became overtly diabetic the increase in mean plasma glucose concentration became manifest.

"In conclusion, the progressive decline in β-cell function that begins in 'normal' glucose tolerant individuals is associated with a progressive increase in FFA and fasting Adipo-IR," the authors write.

Explore further: Vitamin D doesn't improve glucose measures

More information: Full Text (subscription or payment may be required)

Related Stories

Vitamin D doesn't improve glucose measures

October 5, 2016
(HealthDay)—Weekly doses of vitamin D do not improve oral glucose tolerance or markers of glycemic status among those at risk for diabetes, according to a study published online Sept. 26 in Diabetes, Obesity and Metabolism.

SFRP4 linked to impaired glucose tolerance, T2DM

August 1, 2016
(HealthDay)—Secreted frizzled-related protein 4 (SFRP4) is associated with impaired glucose tolerance (IGT) and type 2 diabetes (T2D), according to a report published online July 6 in Diabetes Care.

Progression of dysglycemia in youth similar to adults

July 12, 2014
(HealthDay)—For obese adolescents, glucose sensitivity deteriorates progressively across the spectrum of glucose tolerance, according to a study published online June 19 in Diabetes.

Metabolic benefit same with similar weight loss after surgery

November 21, 2016
(HealthDay)—Early metabolic differences following laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB) in obese individuals with type 2 diabetes mellitus (T2DM) disappear when weight loss reaches ...

Rapid improvement in insulin sensitivity with bariatric surgery

September 5, 2016
(HealthDay)—For obese patients without diabetes, bariatric surgery improves insulin sensitivity (IS), with more pronounced improvements for Roux-en-Y gastric bypass (RYGB) than for laparoscopic adjustable gastric banding ...

Ghrelin may predict cognitive impairment

October 10, 2016
(HealthDay)—Blood levels of ghrelin may be a predictor of executive function impairment in patients with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 30 in the Journal of Diabetes Investigation.

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.